News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Versant Ventures V, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/27/2023 |
4
| Versant Ventures V, LLC (10% Owner) has filed a Form 4 on Turnstone Biologics Corp.|
Txns:
| Converted 2,528,864 shares
@ $0
Converted 192,458 shares
@ $0
Converted 84,313 shares
@ $0
Converted 76,067 shares
@ $0
Converted 274,990 shares
@ $0
Bought 197,458 shares
@ $12, valued at
$2.4M
Bought 15,028 shares
@ $12, valued at
$180.3k
Bought 6,575 shares
@ $12, valued at
$78.9k
Bought 5,939 shares
@ $12, valued at
$71.3k
Converted 7,897,999 preferred shares
@ $0
Converted 601,077 preferred shares
@ $0 |
|
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
SC 13G/A
| Versant Ventures V, LLC reports a 0% stake in Aprea Therapeutics, Inc. |
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Versant Ventures V, LLC (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Disposed of 285,217 shares
@ $0
Disposed of 8,579 shares
@ $0
Disposed of 9,497 shares
@ $0
Disposed of 21,707 shares
@ $0 |
|
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
3
| Versant Ventures V, LLC (10% Owner) has filed a Form 3 on Repare Therapeutics Inc. |
| 05/20/2020 |
4
| Versant V Luxco S.a r.l. (10% Owner) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Disposed of 2,519,323 shares
@ $0
Acquired 2,210,937 shares
@ $0
Acquired 66,506 shares
@ $0
Acquired 73,617 shares
@ $0
Acquired 168,263 shares
@ $0
Disposed of 773,805 shares
@ $0
Disposed of 23,275 shares
@ $0
Disposed of 25,794 shares
@ $0
Disposed of 58,889 shares
@ $0
Acquired 16,428 shares
@ $0
Disposed of 16,428 shares
@ $0 |
|
| 10/18/2019 |
SC 13G
| Versant Ventures V, LLC reports a 12.1% stake in Aprea Therapeutics, Inc. |
| 10/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2018 |
4
| Versant Venture Capital V, L.P. (10% Owner) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 20,071 shares
@ $51, valued at
$1M
Sold 589 shares
@ $50.6, valued at
$29.8k
Sold 653 shares
@ $51, valued at
$33.3k
Sold 1,528 shares
@ $51, valued at
$77.9k
|
|
| 09/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|